Tizanidine Tablet
Product Images NDC 85509-1180
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 85509-1180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig2 (Fig2)
Fig3 (Fig3)
Structure (Structure)
Label (Tiz4label)
This text provides important information about a medication called Tizanidine Tablets, USP. Each tablet contains 4.576 mg of tizanidine hydrochloride USP, which is equivalent to 4 mg of tizanidine base. Users are advised to store the tablets at a temperature between 15°C-30°C (59°F-86°F) and keep them out of reach of children. The tablets should not be interchanged with tizanidine capsules. The package includes 30 tablets and is only available with a prescription. The medication is manufactured by Dr. Reddy's Laboratories Ltd and repackaged by Phoenix RX LLC in Hatboro, PA, USA. The expiration date is July 10, 2026.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.